CN1201804C - Medicine for treating osteoporosis and its preparation method - Google Patents

Medicine for treating osteoporosis and its preparation method Download PDF

Info

Publication number
CN1201804C
CN1201804C CNB031276105A CN03127610A CN1201804C CN 1201804 C CN1201804 C CN 1201804C CN B031276105 A CNB031276105 A CN B031276105A CN 03127610 A CN03127610 A CN 03127610A CN 1201804 C CN1201804 C CN 1201804C
Authority
CN
China
Prior art keywords
medicine
water
radix
polygoni multiflori
filtering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB031276105A
Other languages
Chinese (zh)
Other versions
CN1475252A (en
Inventor
冷向阳
张文泰
赵忠民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaceutical Factory, Bethune Medical Univ.
Original Assignee
冷向阳
张文泰
赵忠民
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 冷向阳, 张文泰, 赵忠民 filed Critical 冷向阳
Priority to CNB031276105A priority Critical patent/CN1201804C/en
Publication of CN1475252A publication Critical patent/CN1475252A/en
Application granted granted Critical
Publication of CN1201804C publication Critical patent/CN1201804C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a medicine for treating osteoporosis and a preparation method, particularly to a medicine for treating osteoporosis. The medicine is prepared by the following steps: grinding hairy antler, partially prepared fleeceflower root, human placenta and Radix Notoginseng into fine powder; processing the partially prepared fleeceflower root by ethanol through reflux extraction to obtain extraction solutions; merging and filtering the extraction solutions, recovering the ethanol, decocting tortoiseshell with water, and then filtering for reserving; extracting the volatile oil of Chinese angelica and amomum fruit with the water; collecting the volatile oil, coating by beta-cyclodextrin later, and then distilling to obtain a water solution; collecting the water solution in other implements for reserving; decocting eucommia bark and dried leech with the water, and then filtering to obtain a filtration solution; placing the filtration solution, mixing herb residues with the reserved herb residues, decocting with the water later, and then filtering; merging the decoction solutions, mixing with the paste extracted by the ethanol later and then adding the fine powder. The medicine of the present invention has the advantages of conspicuous curative effect and relieved side effect on multiple medicine combination.

Description

Osteoporotic medicine of a kind of treatment and preparation method
The present invention relates to the osteoporotic medicine of a kind of treatment.It specifically is the Chinese patent medicine of feedstock production with the Chinese herbal medicine.The invention still further relates to the preparation method of this medicine.
Osteoporosis is a common clinical, one of frequently-occurring disease.Up to nearly attention that just obtained people in 15 years gradually.This sick old people sees more, it is reported, nearly 200,000,000 people in the whole world suffer from osteoporosis at present, and its sickness rate has leapt to the 7th of the various commonly encountered diseases in the world.The sickness rate of China some areas senile osteoporosis disease more than 60 years old reaches 59.87%.International medical community is osteoporosis and hypertension, arteriosclerosis, and diabetes, tumor are listed as old people's important diseases.
Osteoporosis is a systemic disease, and the course of disease is long, and reaches 9.6% because of the incidence rate of the concurrent fracture of osteoporosis.The medical expense that fracture not only makes country and individual bear increases greatly, and has a strong impact on old people's quality of life.Osteoporosis is to reduce and the osseous tissue microstructure is a feature with whole body bone amount, and causes that the fragility of bone increases, and the intensity of bone lowers, in no wound, under the slight and moderate wound situation, the disease that the risk of fractures degree increases, bone mineral and bone matrix equal proportion minimizing this moment.
There is following thorny problem in the domestic and international at present Drug therapy to primary disease:
1 heavy dose of calcium preparation+vitamin D life-time service complication height, weak curative effect.
2 gonadal hormone have potential carcinogenic danger.
Can 3 calcitonins can only the intestinal external administration, costs an arm and a leg, long term administration remain to be observed.
4 diphosphonate adverse effectes are more, and effect is undesirable separately.
Though the Chinese patent medicine of some treatment osteoporosis is also arranged, Chinese medicine calcium preparation, or function blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, patent medicine such as Shujin bone strengthening and warming and recuperating the kidney-YANG, because of its function singleness, curative effect is then unsatisfactory.
The purpose of this invention is to provide a kind of osteoporotic pure Chinese medicinal preparation of treatment that stops and alleviate the degeneration of muscles and bones.
Another object of the present invention provides the preparation method of this osteoporosis preparation.
The traditional theory that solution of the present invention is based on motherland's medical science is the basis, in conjunction with the common disease type of clinical osteoporosis, with reference to the modern pharmacological research achievement, from motherland's medicine treasure-house, filter out liver and kidney tonifying, expelling wind and removing dampness, blood circulation promoting and blood stasis dispelling, the natural drug of promoting the circulation of QI to relieve pain, by the theory of Chinese medical science prescription, skim the cream off milk, give full play to its invigorating the kidney and strengthening the bones, the merit of promoting blood circulation and stopping pain.With pure compound Chinese medicinal preparation, promptly remedied the deficiency of Western medicine, satisfied curative effect is arranged again.
Medicine of the present invention is made by following raw materials according: (consumption is a weight portion)
Cornu Cervi Pantotrichum 2~8 Radix Polygoni Multiflori Preparatas 20~30 Carapax Et Plastrum Testudiniss 18~32
The Cortex Eucommiae 10~25 Placenta Hominiss 5~15 Radix Angelicae Sinensis 10~20
Radix Notoginseng 5~15 Hirudos 3~8 Fructus Amomis 7~15
Raw material preferred weight (part) ratio range of preparation medicine of the present invention is:
Cornu Cervi Pantotrichum 3~6 Radix Polygoni Multiflori Preparatas 22~28 Carapax Et Plastrum Testudiniss 21~29
The Cortex Eucommiae 15~20 Placenta Hominiss 6~10 Radix Angelicae Sinensis 13~17
Radix Notoginseng 5~10 Hirudos 3~5 Fructus Amomis 7~10
The optimum weight of medicine of the present invention (part) proportioning is:
Cornu Cervi Pantotrichum 6 Radix Polygoni Multiflori Preparatas 24 Carapax Et Plastrum Testudiniss 24
The Cortex Eucommiae 18 Placenta Hominiss 6 Radix Angelicae Sinensis 14
Radix Notoginseng 6 Hirudos 3.5 Fructus Amomis 8
Above-mentioned each raw material is made this medicine production method is: get the said medicine raw material by weight preparation, Cornu Cervi Pantotrichum, three/a Radix Polygoni Multiflori Preparata, Placenta Hominis, Radix Notoginseng powder are broken into fine powder; Again with two parts of Radix Polygoni Multiflori Preparatas of its excess-three branch with 70% alcohol reflux secondary, each 2 hours, make a living 7 times of dose of alcohol adding amount, merge extractive liquid, filters, and reclaims ethanol, being concentrated into relative density is the thick paste shape of 1.28-1.30 (60 ℃ of surveys), and Carapax Et Plastrum Testudinis decocts with water three times, extracts 3 successively, 2,2 hours, make a living 8 times of dose of amount of water merge decoction liquor, filter standby, Radix Angelicae Sinensis, Fructus Amomi adds five times of water extraction volatile oil, collects volatile oil and carries out enclose with beta-schardinger dextrin-, and distillation rear solution device is in addition collected, collect standby, the Cortex Eucommiae, Hirudo adds ten times of water gagings, decocts two hours, filters, filtrate is placed, medicinal residues mix with above-mentioned standby medicinal residues, add the octuple water gaging, decoct two hours, filter, merge above-mentioned each decoction liquor, being concentrated into relative density is the thick paste shape of 1.28-1.30 (60 ℃ of surveys), merges with above-mentioned alcohol extraction cream, add above-mentioned fine powder, mixing is made granule, drying, incapsulate, promptly.
The clinical use result of the present invention shows that following advantage is arranged:
1. to select natural Chinese medicinal herb for use be raw material in the present invention, based on the traditional theory of motherland's medical science, and in conjunction with the common disease type of clinical osteoporosis, with reference to the modern pharmacological research achievement, reasonable formula, and through animal and clinical experiment, have no side effect.
2. the present invention is capsule, and is easy to carry, and taking convenience is removed the inconvenience of Chinese medicine decoction from.
3. the present invention uses separately through clinic trial, and is evident in efficacy, takes for a long time and do not find untoward reaction.Remove the untoward reaction that multiple medicines share from, and mutual ill effect between the medicine.
4. the present invention can replace expensive calcitonin, takes for a long time and can reduce medical expense greatly.
The specific embodiment:
Get Cornu Cervi Pantotrichum 60 gram, Radix Polygoni Multiflori Preparata 60 grams, Placenta Hominis 60 grams, Radix Notoginseng 60 grams and be ground into fine powder; Again with 180 parts of usefulness of Radix Polygoni Multiflori Preparata, 70% alcohol reflux secondary, each 2 hours, make a living 7 times of dose of alcohol adding amount, merge extractive liquid, filters, and reclaims ethanol, being concentrated into relative density is the thick paste shape of 1.30 (60 ℃ of surveys), and Carapax Et Plastrum Testudinis 240 grams decoct with water three times, extract 3 successively, 2,2 hours, make a living 8 times of dose of amount of water merge decoction liquor, filter standby, Radix Angelicae Sinensis 140 grams, Fructus Amomi 80 grams add five times of water extraction volatile oil, collect volatile oil and carry out enclose with beta-schardinger dextrin-, and distillation rear solution device is in addition collected, collect standby, the Cortex Eucommiae 180 gram, Hirudo 35 grams add ten times of water gagings, decoct two hours, filter, filtrate is placed, and medicinal residues mix with above-mentioned standby medicinal residues, add the octuple water gaging, decocted two hours, filter, merge above-mentioned each decoction liquor, being concentrated into relative density is the thick paste shape of 1.30 (60 ℃ of surveys), merge with above-mentioned alcohol extraction cream, add above-mentioned fine powder, mixing is made granule, dry, incapsulate, make 1000, promptly.

Claims (4)

1, the osteoporotic medicine of a kind of treatment is characterized in that it is the medicament of being made by the following weight proportion raw material:
Cornu Cervi Pantotrichum 2~8 Radix Polygoni Multiflori Preparatas 20~30 Carapax Et Plastrum Testudiniss 18~32
The Cortex Eucommiae 10~25 Placenta Hominiss 5~15 Radix Angelicae Sinensis 10~20
Radix Notoginseng 5~15 Hirudos 3~8 Fructus Amomis 7~15.
2, the osteoporotic medicine of treatment according to claim 1, wherein the weight proportion of each raw material is:
Cornu Cervi Pantotrichum 3~6 Radix Polygoni Multiflori Preparatas 22~28 Carapax Et Plastrum Testudiniss 21~29
The Cortex Eucommiae 15~20 Placenta Hominiss 6~10 Radix Angelicae Sinensis 13~17
Radix Notoginseng 5~10 Hirudos 3~5 Fructus Amomis 7~10.
3, the osteoporotic medicine of treatment according to claim 1, wherein the weight proportion of each raw material is:
Cornu Cervi Pantotrichum 6 Radix Polygoni Multiflori Preparatas 24 Carapax Et Plastrum Testudiniss 24
The Cortex Eucommiae 18 Placenta Hominiss 6 Radix Angelicae Sinensis 14
Radix Notoginseng 6 Hirudos 3.5 Fructus Amomis 8.
4, according to the preparation method of claim 1, the osteoporotic medicine of 2 or 3 described treatments, it is characterized in that:
Get the said medicine raw material by weight preparation, Cornu Cervi Pantotrichum, three/a Radix Polygoni Multiflori Preparata, Placenta Hominis, Radix Notoginseng powder are broken into fine powder; Again with two parts of Radix Polygoni Multiflori Preparatas of its excess-three branch with 70% alcohol reflux secondary, each 2 hours, make a living 7 times of dose of alcohol adding amount, merge extractive liquid, filters, and reclaims ethanol, being concentrated into relative density is the thick paste shape of 1.28-1.30, and Carapax Et Plastrum Testudinis decocts with water three times, extracts 3 successively, 2,2 hours, make a living 8 times of dose of amount of water, merge decoction liquor, filter standby, Radix Angelicae Sinensis, Fructus Amomi adds five times of water extraction volatile oil, collect volatile oil and carry out enclose with beta-schardinger dextrin-, distillation rear solution in addition device is collected, collect standby, the Cortex Eucommiae, Hirudo adds ten times of water gagings, decocted two hours, filter, filtrate is placed, and medicinal residues mix with above-mentioned standby medicinal residues, add the octuple water gaging, decocted two hours, and filtered, merge above-mentioned each decoction liquor, being concentrated into relative density is the thick paste shape of 1.28-1.30, merge with above-mentioned alcohol extraction cream, add above-mentioned fine powder, mixing, make granule, drying.
CNB031276105A 2003-06-27 2003-06-27 Medicine for treating osteoporosis and its preparation method Expired - Fee Related CN1201804C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB031276105A CN1201804C (en) 2003-06-27 2003-06-27 Medicine for treating osteoporosis and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB031276105A CN1201804C (en) 2003-06-27 2003-06-27 Medicine for treating osteoporosis and its preparation method

Publications (2)

Publication Number Publication Date
CN1475252A CN1475252A (en) 2004-02-18
CN1201804C true CN1201804C (en) 2005-05-18

Family

ID=34153190

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB031276105A Expired - Fee Related CN1201804C (en) 2003-06-27 2003-06-27 Medicine for treating osteoporosis and its preparation method

Country Status (1)

Country Link
CN (1) CN1201804C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104906499A (en) * 2015-06-26 2015-09-16 吴强 Medicine for treating osteoporosis caused by liver-kidney yin deficiency and preparation method of medicine
CN105381283A (en) * 2015-11-30 2016-03-09 杨登新 Chinese herbal preparation for treating osteoporosis and preparation method of Chinese herbal preparation

Also Published As

Publication number Publication date
CN1475252A (en) 2004-02-18

Similar Documents

Publication Publication Date Title
CN1319414A (en) Medicine for treating hecrosis of femoral head
CN1099867C (en) Face-care prepn. contg. natural ingredients
CN1284567C (en) Medicinal liquid for treating osteoporosis and its preparation method
CN1207041C (en) Medicine for treating osteoporosis and its preparing process
CN1170566C (en) Externally applied pain-relieving plaster and its prepn
CN1201804C (en) Medicine for treating osteoporosis and its preparation method
CN104306404A (en) Novel application of periplaneta americana extractive
CN1279944C (en) Medicine for treating cardiocerebral vascular system disease and blood supply deficiency, medicine preparing method and preparation
CN110215485B (en) Traditional Chinese medicine composition for treating diabetic skin ulcer and preparation method thereof
CN102988607A (en) Health-care traditional Chinese medicine composition for osteoporosis
CN100345571C (en) Medication for treating necrosis of femoral head and preparation method
CN1180821C (en) Medicine for treating cerebral thrombus and its prepn
CN1166397C (en) Medicine for treating cardiovascular and cerebrovascular system disease, apoplectic sequel
CN1500513A (en) Instant traditional Chinese medicine formulation for headache
CN1371728A (en) Powder medicine for promoting blood circulation and removing blood stasis
CN1814122A (en) Medicine for treating osteoporosis and preparing method
CN1846733A (en) Externally applied skin care liquid extracted from plant and its prepn process
CN1184995C (en) Kidney-strengthening and pregnancy assisting granule
CN1092968C (en) Pharmaceuticals for treating outer skin blood vessel diease in cold seasons
CN1657080A (en) Oral liquid formula used for treating postparatum blood vacuity and its preparation method
CN1175457A (en) Medicinal composition for treatment of dermatosis
CN1059120C (en) Chinese medicine for treating bone wound
CN1057227C (en) Oral liquid for removing intense heat from throat and preparing process thereof
CN1238005C (en) Spot removing and face nursing capsule
CN1125134A (en) Traditional Chinese medicine for reducing blood-lipid and its preparing technology

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: HU NAN QIU ZEYOU PATENT STRATEGIC PLANNING CO., LT

Free format text: FORMER OWNER: QIU ZEYOU

Effective date: 20101101

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 410011 28/F, SHUNTIANCHENG, NO.59, SECTION 2 OF FURONG MIDDLE ROAD, CHANGSHA CITY, HU NAN PROVINCE TO: 410205 JUXING INDUSTRY BASE, NO.8, LUJING ROAD, CHANGSHA HIGH-TECH. DEVELOPMENT ZONE, YUELU DISTRICT, CHANGSHA CITY, HU NAN PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20101105

Address after: 130012 No. 358, Chuangxin Road, hi tech Zone, Jilin, Changchun

Patentee after: Pharmaceutical Factory, Bethune Medical Univ.

Address before: 130021 Department of Orthopaedics, Changchun Provincial Hospital of traditional Chinese medicine, 1478 workers' road, Jilin, China

Co-patentee before: Zhang Wentai

Patentee before: Leng Xiangyang

Co-patentee before: Zhao Zhongmin

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050518

Termination date: 20140627

EXPY Termination of patent right or utility model